Boehringer Ingelheim: Shashank Deshpande to lead Human Pharma business unit, Carinne Brouillon to retire

Hubertus von Baumbach, Chairman of the Board of Managing Directors added, “I want to thank Shashank for accepting his new role. His Board experience, longstanding leadership in our two largest human pharma markets and his pharma marketing background make him an excellent successor to Carinne, who I wish all the best for the future. I also welcome Armin to our Board. His animal health industry knowledge and deep commercial understanding make him well prepared to continue the transformational work Shashank successfully started in Animal Health.”

Shashank Deshpande joined Boehringer Ingelheim in 2012. Prior to his current Board mandate, he was Country Managing Director in Japan. Earlier, he held human pharma leadership and marketing positions in Japan and Germany. Shashank Deshpande is a highly experienced leader, with a strong business background, who lived and worked across Asia, Europe and North America. He holds a Master’s degree in Business Administration from the University of Hamburg, Germany.

Armin Wiesler joined Boehringer Ingelheim in 2008. Prior to his regional leadership role since 2021, he performed local, regional and global roles in corporate strategy and development, human pharma marketing and animal health. Armin Wiesler was a General Manager in Thailand, worked at Boehringer’s US headquarters and spent six years in corporate roles in Ingelheim. Dr. Wiesler holds a Doctorate and a Master’s degree in Economics from the University of Freiburg, Germany.